1. Home
  2. MIRA vs FTFT Comparison

MIRA vs FTFT Comparison

Compare MIRA & FTFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIRA
  • FTFT
  • Stock Information
  • Founded
  • MIRA 2020
  • FTFT N/A
  • Country
  • MIRA United States
  • FTFT United States
  • Employees
  • MIRA N/A
  • FTFT N/A
  • Industry
  • MIRA Biotechnology: Pharmaceutical Preparations
  • FTFT Business Services
  • Sector
  • MIRA Health Care
  • FTFT Consumer Discretionary
  • Exchange
  • MIRA Nasdaq
  • FTFT Nasdaq
  • Market Cap
  • MIRA 17.1M
  • FTFT N/A
  • IPO Year
  • MIRA 2023
  • FTFT N/A
  • Fundamental
  • Price
  • MIRA $1.05
  • FTFT $0.34
  • Analyst Decision
  • MIRA Strong Buy
  • FTFT
  • Analyst Count
  • MIRA 2
  • FTFT 0
  • Target Price
  • MIRA $14.00
  • FTFT N/A
  • AVG Volume (30 Days)
  • MIRA 552.1K
  • FTFT 144.5K
  • Earning Date
  • MIRA 11-11-2024
  • FTFT 11-18-2024
  • Dividend Yield
  • MIRA N/A
  • FTFT N/A
  • EPS Growth
  • MIRA N/A
  • FTFT N/A
  • EPS
  • MIRA N/A
  • FTFT N/A
  • Revenue
  • MIRA N/A
  • FTFT $37,105,708.00
  • Revenue This Year
  • MIRA N/A
  • FTFT N/A
  • Revenue Next Year
  • MIRA N/A
  • FTFT N/A
  • P/E Ratio
  • MIRA N/A
  • FTFT N/A
  • Revenue Growth
  • MIRA N/A
  • FTFT 84.77
  • 52 Week Low
  • MIRA $0.51
  • FTFT $0.29
  • 52 Week High
  • MIRA $6.40
  • FTFT $2.60
  • Technical
  • Relative Strength Index (RSI)
  • MIRA 38.97
  • FTFT 51.19
  • Support Level
  • MIRA $1.04
  • FTFT $0.30
  • Resistance Level
  • MIRA $1.20
  • FTFT $0.36
  • Average True Range (ATR)
  • MIRA 0.07
  • FTFT 0.03
  • MACD
  • MIRA 0.02
  • FTFT 0.00
  • Stochastic Oscillator
  • MIRA 19.44
  • FTFT 58.43

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Share on Social Networks: